SACCOMANO NICHOLAS A (President and CEO) sold 0.8% of their position (86.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $378.08 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/24/2026ACC: 0001609284-26-000003
DirectorOfficer· President and CEO
Since Oct 2024
-86.00
Net shares
Net seller
$378.08
Total sold
1
Open market trades
0B · 1S
1
Total transactions
86.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−86.00
Price / share
$4.40
Trade value
$378.08
% of position
0.8%
6/22/2026
11.33K→11.25K
Total
Net shares
−86.00
Net value
-$378.08
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/22/2026 | S · Sale | −86.00 | $4.40 | $378.08 | 0.8% | 11.33K | 11.25K |
| Total | −86.00 | -$378.08 | ||||||
Derivative Transactions0
No derivative transactions reported